120 results

• BPA Exposure Before Birth Could Lead to Breathing Problems For Children: Study

  October 8, 2014

  Martha Garcia

  Exposure to BPA during pregnancy could result in childhood breathing problems, according to a new study.

• Xolair Side Effects May Cause Heart Problems, Cancer: FDA Warns

  September 29, 2014

  Austin Kirk

  The FDA is warning that the asthma drug Xolair may increase the risk of blood vessel problems in the brain and heart.

• Singulair Does Not Help Most Children Stop Wheezing: Study

  September 12, 2014

  Martha Garcia

  Researchers say the asthma drug Singulair does not provide significant benefits to children with respiratory problems.

• Advair Settlement Agreement Reached With 45 States for $105M

  June 5, 2014

  Irvin Jackson

  GlaxoSmithKline will pay 45 states $105 million for illegally marketing the asthma drug Advair.

• Incivek, Xolair Linked to Severe, Sometimes Deadly Reactions: Report

  May 9, 2014

  Irvin Jackson

  The drugs Incivek and Xolair are linked to an alarming number of severe and sometimes deadly hypersensitivity adverse event reports, according to a new analysis.

• Singulair Allergy Risks Are Too Dangerous for Over-the-Counter Use: Group

  May 6, 2014

  Irvin Jackson

  Public Citizen is urging the FDA to reject OTC Singulair Allergy drug approval, saying it is too dangerous with too few proven benefits.

• Effects of Bisphenol A (BPA) Exposure Seen Even at Low Doses: Study

  November 13, 2013

  Martha Garcia

  A new study finds BPA side effects at doses lower than currently accepted as safe.

• Brovana Claims Misleading, Side Effects Minimized: FDA Warning Letter

  November 4, 2013

  Martha Garcia

  Ads for Brovana inhalers are misleading and downplay the side effects, the FDA has warned the company.

• Asthmanefrin and EZ Breathe Atomizer Problems Result in FDA Warning

  October 7, 2013

  Martha Garcia

  The FDA is warning of severe adverse reactions from Asthmanefrin, which has only been on the market a year.

• Hyperbaric Oxygen Therapy Ads May Be Misleading, Dangerous: FDA

  August 23, 2013

  Martha Garcia

  Misleading ads for hyperbaric chamber oxygen treatments could put patients at risk for little if any benefits, the FDA warns.